Yi Hsu Huang
Director/Board Member at ADVAGENE BIOPHARMA CO., LTD.
Profile
Yi Hsu Huang was the founder of Mycenax Biotech, Inc. founded in 2001, where he held the title of Director from 2013 to 2019.
Currently, he is the Chief Executive Officer-Bioproduction Plant at National Health Research Institutes and a Director at Advagene Biopharma Co., Ltd.
since 2016.
He previously worked as the Chief Technology Officer & Deputy General Manager at Medigen Vaccine Biologics Corp.
Dr. Huang holds a doctorate degree from Auburn University and a graduate degree from Northwestern State University.
Yi Hsu Huang active positions
| Companies | Position | Start |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 2016-04-05 |
| National Health Research Institutes | Corporate Officer/Principal | - |
Former positions of Yi Hsu Huang
| Companies | Position | End |
|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chief Tech/Sci/R&D Officer | 2021-04-30 |
| MYCENAX BIOTECH INC. | Founder | 2019-08-14 |
Training of Yi Hsu Huang
| Auburn University | Doctorate Degree |
| Northwestern State University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| ADVAGENE BIOPHARMA CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
| National Health Research Institutes |
- Stock Market
- Insiders
- Yi Hsu Huang
